ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
COMPASS Pathways PLC

COMPASS Pathways PLC (CMPS)

4.53
-0.01
(-0.22%)
Closed December 11 4:00PM
4.53
0.00
( 0.00% )
Pre Market: 7:13AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
4.53
Bid
4.48
Ask
4.63
Volume
111
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
4.53
Open
-
Last Trade
10
@
4.5
Last Trade Time
08:06:27
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
68,390,000
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
4.88M
Net Profit
-118.46M

About COMPASS Pathways PLC

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing ther... Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360. Show more

Sector
Offices-holdng Companies,nec
Industry
Offices-holdng Companies,nec
Headquarters
Cheshire, Gbr
Founded
-
COMPASS Pathways PLC is listed in the Offices-holdng Companies sector of the NASDAQ with ticker CMPS. The last closing price for COMPASS Pathways was $4.53. Over the last year, COMPASS Pathways shares have traded in a share price range of $ 0.00 to $ 0.00.

COMPASS Pathways currently has 68,390,000 shares outstanding. The market capitalization of COMPASS Pathways is $309.81 million.

CMPS Latest News

Compass Pathways to Participate in December Investor Conferences

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that members of the executive...

Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates

Top-line COMP005 data for COMP360 phase 3 pivotal program in treatment-resistant depression now expected in second quarter 2025 COMP006 data will now be announced after 26-week time point...

Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PALIPalisade Bio Inc
$ 3.11
(122.14%)
23.13M
TRVITrevi Therapeutics Inc
$ 3.55
(42.57%)
3.92M
SYTASiyata Mobile Inc
$ 1.04
(39.04%)
17.48M
ZENAZenaTech Inc
$ 7.1972
(26.49%)
6.36M
CDTConduit Pharmaceuticals Inc
$ 0.1096
(24.12%)
38.47M
KROSKeros Therapeutics Inc
$ 18.67
(-72.80%)
904.17k
SPGCSacks Parente Golf Inc
$ 0.54
(-61.43%)
230.29k
AVGRAvinger Inc
$ 0.441
(-46.22%)
111.05k
TFFPTFF Pharmaceuticals Inc
$ 0.10
(-38.54%)
643.22k
HEPAHepion Pharmaceuticals Inc
$ 0.36
(-38.46%)
19
CDTConduit Pharmaceuticals Inc
$ 0.1096
(24.12%)
38.47M
PALIPalisade Bio Inc
$ 3.11
(122.14%)
23.13M
SYTASiyata Mobile Inc
$ 1.04
(39.04%)
17.48M
AMPGAmplitech Group Inc
$ 2.27
(17.62%)
14.65M
LAESSEALSQ Corporation
$ 1.2899
(12.17%)
10.48M

CMPS Discussion

View Posts
MomsSpaghetti MomsSpaghetti 1 month ago
ooof! Glad I didn't have this one. ATAI recently got rid of most of their share of CMPS which was good after this news.

MNMD and ATAI for the win in this sector.
πŸ‘οΈ0
dinogreeves dinogreeves 4 months ago
Awesome mid to long term hold. Could see 30-40 dollars by end of the year.
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
CMPS new 52 week high
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
CMPS new 52=week high
πŸ‘οΈ0
Copilotdog Copilotdog 1 year ago
There will be no mushroom boom. The Fed’s will crush it. Shorting this to $3
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
This podcast is an absolute screaming hilarious analysis of psycho stocks
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
Uh, you know, we live now in technology driven world
In times past ever since the Industrial Revolution wealth was created primarily from natural resources
But that isn’t exactly the etched in stone fact
Prior to the mid-1850s there was the Scientific Revolution that began in the 1400s
The academic discipline of chemistry in some unforeseen way led to the accidental discovery by a Swiss chemist who walked to his lab well into his 80s
That said, as far as US stock market sectors are concerned, the medical sector is by far the largest in terms of the number of companies in which a retail or professional asset manager deploying other people’s money can invest
Close to 1 000 public traded companies
It is in my view pretty much a crap shoot when it comes finding one that is equivalent to Microsoft
With that said one should, in the long run, expect disappointment to be the norm rather than the exception
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 1 year ago
Last time I owned this, was when I sold it over $70, really dodged a bullet on this one.. unfortunately I own MNMD.. and it’s just as bad of a fall down shit show
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
CMPS new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
CMPS over $10

https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
CMPS nearing resistance break it and it goes higher
πŸ‘οΈ0
Denisnj Denisnj 2 years ago
Definitely overpriced. Government needs slaves. No way they'll let humanity awaken
πŸ‘οΈ0
starman2 starman2 2 years ago
https://investorplace.com/2022/07/dear-psychedelic-stocks-fans-watch-this-key-catalyst/
πŸ‘οΈ0
starman2 starman2 2 years ago
https://www.benzinga.com/analyst-ratings/analyst-color/22/08/28522479/these-depression-players-are-hc-wainwrights-top-picks-for-400b-mental-healthcare-ma

(shared via bit.ly/mystocksapp)
πŸ‘οΈ0
starman2 starman2 2 years ago
On fire.. So glad i jumped in.
πŸ‘οΈ0
ListenToMe ListenToMe 3 years ago
Are you peeps watching PSYCF? I definitely think it's going to become the LEADER and Catalyst for the Mushroom sector!
πŸ‘οΈ0
ListenToMe ListenToMe 3 years ago
Best mushroom play is PSYCF!!! Pay Attn.


.PSYCF





.
πŸ‘οΈ0
ListenToMe ListenToMe 3 years ago
Awesome mushroom video & sound https://mobile.twitter.com/PsychedWellness/status/1478556314309648389
πŸ‘οΈ0
BesaoT35 BesaoT35 3 years ago
Psychedelics are very safe drugs. A long term remission in treatment resistant major depression is a highly valuable and rare benefit to achieve for these patients.

On occasion there are reported cases of a psychosis induced, usually when that happens it is on very large doses of psychedelics perhaps combined with a non supportive environment.

Psilocybin causes fewer of these outcomes I have heard and is perhaps a less intense experience. Psilocybin is known to be a shorter acting psychedelic than LSD is.

Sedatives such as Valium or Xanax should be available if needed or desired at the end of the session in my opinion. Otherwise the process of coming down from the peak experience can be a drawn out and somewhat unpleasant process.
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 3 years ago
I love this stock!! Just flipped this for a $1500 profit in 24 hrs..
πŸ‘οΈ0
BesaoT35 BesaoT35 3 years ago
The clinical study for Treatment Resistant Major Depression looked very successful. Can a psychiatrist prescribe this patented psilocybin similar to how cannabis is illegal but medical doctors recommend it’s use legally for medical dispensaries?

How are they able to patent a known plant chemical? They claim to have a patented form of psilocybin.
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 3 years ago
Thank god I sold this.
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 3 years ago
This stock has really come back nicely!!
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 3 years ago
Awesome, just made $7700 on this trade!!!
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 3 years ago
Crushing upward today!!
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 3 years ago
Nice volume and nice price movement
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 3 years ago
This thing is moving up!!!
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 3 years ago
Big news today!!!
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 3 years ago
Steady increases, looks like we can get past $40 and then maybe $50?
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 3 years ago
WTF???
πŸ‘οΈ0
Glider549 Glider549 3 years ago
Sure was.
Schroom pharma is really advancing.
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 3 years ago
Nice movement today
πŸ‘οΈ0
Tower of Hanoi Tower of Hanoi 3 years ago
Nice interview. Now that ketamine therapy is in use, I really don't see any significant roadblocks to further expansion into other drugs.

Execution will be critical, plus how many competitors end up in the space.
πŸ‘οΈ0
Investopotia Investopotia 3 years ago
New CEO Interview
πŸ‘οΈ0
Tower of Hanoi Tower of Hanoi 4 years ago
I can't think of a better speculative space right now!

GLTA!
πŸ‘οΈ0
Tower of Hanoi Tower of Hanoi 4 years ago
Tiny, tiny position today:

10 shares @35.

Nice spec.


MY OPINION ONLY.
πŸ‘οΈ0
0001-stocks 0001-stocks 4 years ago
NEW BOARD!!! Psychedelic Stocks (link here)

https://investorshub.advfn.com/Psychedelic-Stocks-39490/
πŸ‘οΈ0
ReviveThomas ReviveThomas 4 years ago
I've eyeballed CMPS but not new to shroom stocks. What's the deal with this. Clinicaltrials.gov trial for treatment resistant depression in may ? Is that right?
πŸ‘οΈ0
TRUSTUNITS1000000 TRUSTUNITS1000000 4 years ago
Up 4.05
πŸ‘οΈ0
TRUSTUNITS1000000 TRUSTUNITS1000000 4 years ago
Going up
πŸ‘οΈ0
TRUSTUNITS1000000 TRUSTUNITS1000000 4 years ago
Could this we thousands dollar stock lollllll
πŸ‘οΈ0
TRUSTUNITS1000000 TRUSTUNITS1000000 4 years ago
Wowwwwwww
πŸ‘οΈ0
WebSlinger WebSlinger 4 years ago
***PR OUT***

COMPASS Pathways plc to participate in HC Wainwright and ICR investor conferences

London, UK, Jan. 06, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that members of its management team will participate in two investor conferences during the week of 11 January 2021.

George Goldsmith, Chairman, CEO and Co-founder, and Lars Wilde, President, Chief Business Officer, and Co-founder, will be participating in a fireside chat available on demand from 11 to 14 January in conjunction with the HC Wainwright BioConnect 2021 Conference.

George Goldsmith and Lars Wilde will also present a business update and hold a fireside chat at 12:15 pm ET on 14 January at the Westwicke Healthcare Day at the ICR Conference 2021.

Audio webcasts of the fireside chats will be available on the "Events" page of the Investors section of the COMPASS website at https://ir.compasspathways.com/news-events/events. A replay of events will be available for 30 days following the event.

https://www.globenewswire.com/news-release/2021/01/06/2154099/0/en/COMPASS-Pathways-plc-to-participate-in-HC-Wainwright-and-ICR-investor-conferences.html
πŸ‘οΈ0
excboe excboe 4 years ago
CMPS ARTICLE. Sketchy https://www.google.com/amp/s/qz.com/1454785/a-millionaire-couple-is-threatening-to-create-a-magic-mushroom-monopoly/amp/
πŸ‘οΈ0
TRUSTUNITS1000000 TRUSTUNITS1000000 4 years ago
Wowwwwww so much cash
πŸ‘οΈ0
WebSlinger WebSlinger 4 years ago
CMPS has $196.5 MILLION in cash (as of 30 Sep 2020)

That should hold them for about 4 years at the current burn rate of about $50 million per year.

https://sec.report/Document/0001628280-20-016249/
πŸ‘οΈ0
Fress Fress 4 years ago
Anxiety depression drug companies.
1.VTGN market cap $150 million 115 million in cash has Phase 3 & Phase 2's (Pandemic through U.S. FDA's Coronavirus Treatment Acceleration Program (CTAP)
2 $CMPS2.0 BILLIION early trials 180 million cash
3 $MMED 1.1 BILLION phase 2 raised 40 million in cash
4 $SAGE 3 Billion market cap bought out a few weeks ago for deperession anxiety pipeline


$CMPS
πŸ‘οΈ0
weedtrader420 weedtrader420 4 years ago
CMPS $70 Target price this week
πŸ‘οΈ0
weedtrader420 weedtrader420 4 years ago
CMPS on the road to $100 woohooooooooo
πŸ‘οΈ0
MomsSpaghetti MomsSpaghetti 4 years ago
I am in this and MMEDF. Both of these are the horses.
πŸ‘οΈ0